TEL-Drug Delivery at the Annual Meeting of the DGBM

Symbolbild zum Artikel. Der Link öffnet das Bild in einer großen Anzeige.

7. October 2024

Gesa Waßmuth presented her latest research in the TEL-Drug Delivey Project with the title “Archaeal Tetraether Lipids as a Platform for the Oral Application of mRNA Vaccines” at the Annual Meeting of the German Society for Biomaterials, from 10-12 October in Berlin. The project is funded by the Bundesministerium für Wirtschaft und Energie (Speziallipide, funding number: 16LP403003).